ArticleBMC cardiovascular disorders2026
BiatriaL cardiac extension of Burkitt lymphoma: a case report of successful surgical correction.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrimary cardiac tumors are rare, and cardiac involvement by Burkitt lymphoma is exceptionally uncommon, particularly when presenting with extensive intracavitary growth. Such tumors may rapidly lead to hemodynamic compromise due to obstruction of venous inflow and impairment of cardiac filling, often requiring urgent surgical intervention. Establishing cardiopulmonary bypass in these settings may be technically challenging, especially when conventional inferior vena cava cannulation is precluded by tumor extension. CASE PRESENTATION: We report a unique case of a 30-year-old male who presented with acute heart failure and severe hemodynamic instability caused by massive biatrial involvement of Burkitt lymphoma. Imaging revealed large intracavitary tumors extending into the inferior vena cava and pulmonary veins, resulting in near-complete obstruction of venous return. During emergency surgery, standard inferior vena cava cannulation and snaring were not feasible due to tumor invasion. To achieve adequate venous drainage and enable cardiopulmonary bypass, an unconventional technique using a cuffed endotracheal tube as a temporary inferior vena cava cannula was successfully employed. This approach allowed effective tumor debulking, restoration of intracardiac blood flow, and subsequent initiation of definitive systemic chemotherapy. Histopathological and molecular analysis confirmed Burkitt lymphoma with a high proliferative index and c-MYC gene translocation. At one-year follow-up, the patient demonstrated complete metabolic remission on ¹⁸F-FDG PET/CT (Deauville score 1).
conclusionsThis case illustrates the critical role of emergency surgical intervention as a bridge to definitive chemotherapy in life-threatening cardiac lymphoma. Our experience extends the applicability of endotracheal tube-assisted venous cannulation beyond its original description and suggests that this technique may serve as a valuable bailout option in emergency cardiac oncology surgery when conventional inferior vena cava cannulation is technically impossible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.